An open-label, single-dose, non-randomized, balanced design three-way cross-over study to examine the variability in absorption of GSK561679 using gamma scintigraphy, PillCam SB capsule and the acoustic vest in healthy males volunteers

Trial Profile

An open-label, single-dose, non-randomized, balanced design three-way cross-over study to examine the variability in absorption of GSK561679 using gamma scintigraphy, PillCam SB capsule and the acoustic vest in healthy males volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Oct 2009

At a glance

  • Drugs Verucerfont; Verucerfont
  • Indications Depressive disorders; Irritable bowel syndrome; Social phobia
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 24 Apr 2008 Status changed from initiated to completed according to ClinicalTrials.gov.
    • 16 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top